Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Tablets × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 15 OTHER_GOV 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Genetic Diseases, Inborn 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 37 Docetaxel 29 Paclitaxel 26 Doxorubicin 24 Trastuzumab 23 Tamoxifen 23 Radiotherapy 18 Epirubicin 13 Letrozole 11 Fluorouracil 9 Lapatinib 8 Capecitabine 8 Bevacizumab 8 Anastrozole 8 exemestane 7 Immunohistochemistry 7 Gene Expression Profiling 7 Filgrastim 7 Zoledronic Acid 6 Surgical Procedures, Operative 6 Methotrexate 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 palbociclib 5 Microarray Analysis 5 Carboplatin 5 Absorptiometry, Photon 5 pertuzumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05392608 2025-09-17

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡